Victrelis: Uses, Dosage, Side Effects & Warnings - Drugs.com
2023年8月23日 · What is Victrelis? Victrelis is an antiviral medicine that prevents certain viruses from multiplying in your body. Victrelis is used in combination with peginterferon alfa and …
VICTRELIS is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection, in combination with peginterferon alfa and...
Boceprevir - Wikipedia
Boceprevir (INN, trade name Victrelis) is a protease inhibitor used to treat hepatitis caused by hepatitis C virus (HCV) genotype 1. [2][3] It binds to the HCV nonstructural protein 3 active …
Victrelis: Package Insert / Prescribing Info - Drugs.com
2024年3月25日 · VICTRELIS is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection, in combination with …
Victrelis (boceprevir) Information - FDA
Victrelis is a hepatitis C virus (HCV) protease inhibitor used with the medicines peginterferon alfa and ribavirin to treat chronic (long-lasting) hepatitis C infection in adults who...
Boceprevir: Hepatitis C Uses, Warnings, Side Effects, Dosage - MedicineNet
Boceprevir is a man-made antiviral medication that targets hepatitis C virus (HCV). Similar drugs include simeprevir (Olysio) and telaprevir (Incivek). These drugs are called direct-acting …
VICTRELIS is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection, in combination with peginterferon alfa and...
Boceprevir (oral route) - Mayo Clinic
Boceprevir is used in combination with injectable peginterferon alfa (Pegasys®, Pegintron®) and ribavirin (Copegus®, Rebetol®) to treat chronic hepatitis C infection. These medicines are …
Victrelis Dosage Guide - Drugs.com
2024年1月22日 · The dose of VICTRELIS is 800 mg (four 200-mg capsules) three times daily (every 7 to 9 hours) with food [a meal or light snack] (see Table 1). Refer to the prescribing …
VICTRELIS™ (boceprevir) Capsules - GlobalRPH
VICTRELIS™ (boceprevir) is indicated for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients (18 years and …
- 某些结果已被删除